Robert G. Miller
0000-0002-9235-3158
Publication & Citation Trends
Publications
0 total
Phase 2B randomized controlled trial of NP001 in amyotrophic lateral sclerosis: Pre‐specified and post hoc analyses OA
Cited by 23
Semantic Scholar
A randomized placebo‐controlled phase 3 study of mesenchymal stem cells induced to secrete high levels of neurotrophic factors in amyotrophic lateral sclerosis OA
Cited by 84
Semantic Scholar
Therapeutic trials in amyotrophic lateral sclerosis: past, present and future
Cited by 0
Semantic Scholar
Addressing heterogeneity in amyotrophic lateral sclerosis CLINICAL TRIALS OA
Cited by 88
Semantic Scholar
Revised Airlie House consensus guidelines for design and implementation of ALS clinical trials OA
Cited by 131
Semantic Scholar
Improving symptom management for people with amyotrophic lateral sclerosis OA
Cited by 56
Semantic Scholar
Mexiletine for muscle cramps in amyotrophic lateral sclerosis: A randomized, double‐blind crossover trial OA
Cited by 47
Semantic Scholar
Mexiletine for Muscle Cramps in ALS: A Randomized Double-Blind Crossover Trial
Cited by 2
Semantic Scholar
Novel trial design in a clinical study of Diaphragm Pacing (DPS) for ALS
Cited by 1
Semantic Scholar
ALSUntangled No. 36: Accilion OA
Cited by 1
Semantic Scholar
Research Topics
Amyotrophic Lateral Sclerosis Research
(74)
Neurogenetic and Muscular Disorders Research
(41)
Peripheral Neuropathies and Disorders
(26)
Parkinson's Disease Mechanisms and Treatments
(12)
Genetic Neurodegenerative Diseases
(12)
Affiliations
Cedars-Sinai Medical Center
Tufts Medical Center
Montreal Neurological Institute and Hospital
San Francisco General Hospital
National Institutes of Health